12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's after-market session, several healthcare stocks experienced significant movements. Altimmune (ALT) saw a 45.2% increase, while Ampio Pharmaceuticals (AMPE) dropped by 20.5%. Other notable gainers include NovaBay Pharmaceuticals (NBY), China Pharma Holding (CPHI), NeuBase Therapeutics (NBSE), Minerva Surgical (UTRS), and Akanda (AKAN). On the losing side, Corbus Pharmaceuticals (CRBP), Eagle Pharmaceuticals (EGRX), bioAffinity Technologies (BIAF), Quoin Pharmaceuticals (QNRX), and LumiraDx (LMDX) saw declines in their stock prices.
November 30, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ampio Pharmaceuticals' shares fell by 20.5% to $4.58, with a market value of $3.8 million.
The substantial after-market decline in Ampio Pharmaceuticals' stock price indicates negative investor sentiment or response to recent events, likely leading to a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Akanda's stock increased by 7.95% to $0.53, with a market cap of $2.0 million.
Akanda's after-market stock price increase suggests potential short-term gains for investors.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Altimmune's stock rose by 45.2% to $4.59, with a market cap of $246.6 million.
The significant after-market increase in Altimmune's stock price suggests positive investor sentiment or reaction to news, which could lead to a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
China Pharma Holding's shares rose by 9.63% to $0.12, with a market value of $3.9 million.
The increase in China Pharma Holding's stock price after-market may suggest a positive short-term outlook for the stock.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
NeuBase Therapeutics' stock moved upwards by 9.48% to $1.08, with a market cap of $4.0 million.
NeuBase Therapeutics' after-market increase may indicate a bullish trend in the short term for the stock.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
NovaBay Pharmaceuticals' stock increased by 9.89% to $0.33, with a market value of $2.1 million.
NovaBay Pharmaceuticals' after-market rise could attract investor interest, potentially leading to a short-term positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Minerva Surgical's stock increased by 8.1% to $2.0, with a market value of $17.7 million.
The positive movement in Minerva Surgical's stock after-market could lead to a short-term positive impact on its stock price.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80